- PROFESSOR AND SYSTEM CHAIR Emergency Medicine
American Board of Emergency Medicine
MD, Georgetown Univ. School of Medicine
Residency, Internal Medicine
Naval Hospital Bethesda (NHB)
Residency, Emergency Medicine
Georgetown University Hospital
- Andy Jagoda, M.D., is Professor and Chair in the Department of Emergency Medicine at Mount Sinai School of Medicine, New York. He also is the Director of The Mount Sinai Hospital's Emergency Medicine Department. He is nationally recognized for his involvement in emergency medicine education and for his work in the areas of neurologic emergencies.
In the News
Chairman and Director of the Department of Emergency Medicine, Dr. Jagoda, discusses heat related illnesses in The Daily News feature The Daily Check Up. View the Pdf.
Jagoda A. Good Housekeeping Family First Aid Handbook, 2nd Edition. Hearst Publishers;.
Henry G, Jagoda A, Little N, Pelligrino T. Neurologic Emergencies. New York, McGraw Hill;.
Jagoda A, Sloan . Seizure Management in the Emergency Department. Ann Emerg Med (Suppl) 2008 Summer;.
Jagoda A. TIA Diagnosis and Management in the Emergency Department. Ann Emerg Med (Suppl) 2008 Summer;.
Jagoda A, . Brain Trauma Foundation Writing Team. Guidelines for prehospital management of severe traumatic brain injury. Prehospital Emergency Care 2007; 12 (supplement): S1-S50.
Napoli A, Jagoda A. Clinical Policies: Their history, future, medical legal implications, and growing importance to physicians. J Emerg Med 2007; 33: 425-432.
Hermann L, Jagoda A. Cardiac Emergencies Part I. Mount Sinai Journal of Medicine 2006; 73(1).
Hermann L, Jagoda A. Cardiac Emergencies Part II. Mount Sinai Journal of Medicine 2006; 73(2).
Jagoda A, Cantrill S, Wears R, Valadka A, Gallagher EJ, Gottesfeld SH, Pietrzak MP, Bolden J, Bruns JJ Jr., Zimmerman R, American College of Emergency Physicians . Clinical Policy: Neuroimaging and decisionmaking in adult mild traumatic brain injury in the acute setting. Ann Emerg Med 2002; 40: 231-249.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Jagoda during 2013 and/or 2014. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- Banyan Biomarkers; Pfizer Inc.; Teva Pharmaceutical Industries Ltd.
Scientific Advisory Board:
- Janssen Pharmaceuticals, Inc.; UCB S.A.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
One Gustave L. Levy Place
New York, NY 10029